Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of all issues and individual articles published by the Journal since 1997.

Antineoplastic Drug Contamination on the Outside of Prepared Infusion Bags

Author(s):  Breukels Oscar, van der Gronde Toon, Simons-Sanders Kathleen, Crul Mirjam

Issue:  Jul/Aug 2018 - Volume 22, Number 4
View All Articles in Issue

Page(s):  345-349

Antineoplastic Drug Contamination on the Outside of Prepared Infusion Bags Page 1
Antineoplastic Drug Contamination on the Outside of Prepared Infusion Bags Page 2
Antineoplastic Drug Contamination on the Outside of Prepared Infusion Bags Page 3
Antineoplastic Drug Contamination on the Outside of Prepared Infusion Bags Page 4
Antineoplastic Drug Contamination on the Outside of Prepared Infusion Bags Page 5

Download in electronic PDF format for $75

Abstract:  Eight Dutch hospital pharmacies took wipe samples of prepared infusion bags containing 5 fluorouracil just before distribution to the wards. The samples were tested with high-performance liquid chromatography and triple quadrupole mass spectroscopy. The limit of detection was 10 ng per swipe. None of the 146 samples had a detectable amount of 5-fluorouracil. The outside of infusion bags containing antineoplastic drugs prepared in these eight Dutch hospital pharmacies were not contaminated and, therefore, were not a risk factor with regard to exposure of hospital workers to antineoplastic drugs.

Related Keywords: hospital pharmacy, prepared infusion bags, 5-fluorouracil, compounded cytotoxic agents, occupational exposure, workplace exposure, antineoplastic drugs, hazardous drugs, wipe tests, infusion bag contamination

Related Categories: CANCER AND AIDS, INFUSION, PACKAGING, PEER-REVIEWED, QUALITY CONTROL, HAZARDOUS DRUGS

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Antineoplastic Drug Contamination on the Outside of Prepared Infusion Bags
Breukels Oscar
, van der Gronde Toon, Simons-Sanders Kathleen, Crul Mirjam
Jul/Aug 2018
Pg. 345-349

Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs
Dillon L R
Jan/Feb 2020
Pg. 30-36

Basics of Compounding for Hazardous Drugs, Part 2: Regulation and Sources of Contamination
Allen Loyd V Jr
Nov/Dec 2006
Pg. 446-448

Zinc Content of Commercial Diluents Widely Use in Drug Admixtures Prepared for Intravenous Infusion
Desai Narendra R
, Shah Syed M, Koczone Julianna, Vencl-Joncic Maja, Sisto Christopher, Ludwig Stephen A
Sep/Oct 2007
Pg. 426-432

Evaluation of Closed-system Transfer Devices in Reducing Potential Risk for Surface Contamination Following Simulated Hazardous-drug Preparation and Compounding
Soefje Scott
, Rickabaugh Keith, Rajkumar Rahul, Wall Kathryn P
Nov/Dec 2021
Pg. 515-522

Evaluation of Closed-system Transfer Devices in Reducing Potential Risk for Surface Contamination Following Simulated Hazardous-drug Preparation and Compounding (Reprint)
Soefje Scott
, Rickabaugh Keith, Rajkumar Rahul, Wall Kathryn P
Jan/Feb 2022
Pg. 72-79

Preparing Nonsterile and Sterile Hazardous Compounds in an Institutional Setting
McElhiney Linda F
Jul/Aug 2009
Pg. 300-310

How to Develop and Maintain a Hazardous Drug List
Dillon L Rad
May/Jun 2019
Pg. 182-186

PreScription: Permissible Exposure Limits and United States Pharmacopeia Chapter <800>
Allen Loyd V Jr
Sep/Oct 2021
Pg. 356

Compounding Using Hazardous Drugs
Lau Kellie
Jul/Aug 2000
Pg. 261-263

PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs
Allen Loyd V Jr
Sep/Oct 2017
Pg. 356

Stability of Gentamicin Sulfate and Tobramycin Sulfate in AutoDose Infusion System Bags
Xu Quanyun A
, Trissel Lawrence A, Saenz Christopher A, Ingram Delshalonda S
Mar/Apr 2002
Pg. 152-154

Basics of Compounding for Hazardous Drugs, Part 4: Developing the Hazardous Drugs List and Containment Workstations
Allen Loyd V Jr
Mar/Apr 2007
Pg. 149-151

Development of Stable and Simple Finasteride 333-μg/mL Suspensions that Minimize Occupational Exposure
Ma Nathan
, Perks William, Law Shirley, Iazzetta John, Walker Scott
Nov/Dec 2020
Pg. 519-527

Roboticized Compounding of Oncology Drugs in a Hospital Pharmacy
Palma Elisabetta
, Bufarini Celestino
Sep/Oct 2014
Pg. 358-364

In-use Stability of Ceftaroline Fosamil in Elastomeric Home Infusion Systems and MINI-BAG Plus Containers
Bhattacharya Sisir
, Parekh Satish, Dedhiya Mahendra
Sep/Oct 2015
Pg. 432-436

Hazardous Drug Enteral Device: A Closed System Device for Crushing and Dispersing Hazardous Drug Tablets for Enteral Administration
Lopez C Vidal
, Rios GL Quito
Sep/Oct 2022
Pg. 358-362

Physiochemical Stability of Diluted Trastuzumab Infusion Solutions in Polypropylene Infusion Bags
Kaiser Jeanette
, Kramer Irene
Nov/Dec 2011
Pg. 515-520

Basics of Compounding for Hazardous Drugs, Part 1: An Introduction
Allen Loyd V Jr
Sep/Oct 2006
Pg. 377-379

Formulation Development and Stability Testing of Extemporaneous Suspension Prepared From Dapsone Tablets
Kaila Nitin
, El-Ries Mohamed, Riga A, Alexander Kenneth S, Dollimore D
May/Jun 2003
Pg. 233-239

Return to Top